NVAX FY 2014 Earnings — Novavax, Inc. Revenue & Financial Results | Market Cap Arena

NVAXNovavax, Inc.

$2B

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$31M+46.6% YoY

Gross Profit

$16M51.1% margin

Operating Income

-$84M-273.0% margin

Net Income

-$83M-270.5% margin

EPS (Diluted)

$-7.35

Cash Flow

Operating Cash Flow

-$67M

Free Cash Flow

-$74M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$276M

Total Liabilities

$46M

Stockholders' Equity

$230M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$21M	+46.6%
Gross Profit	$16M	$13M	+23.5%
Operating Income	-$84M	-$52M	-59.6%
Net Income	-$83M	-$52M	-59.6%